Alnylam Pharmaceuticals Inc.

In News

Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts - Yahoo Finance

Yahoo Finance - Jun 09, 2026

Alnylam, Inceptive sign up to $2 billion AI drug discovery deal - Reuters

Reuters - Jun 03, 2026

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics - Business Wire

Business Wire - Jun 03, 2026

How a US$2 Billion Generative AI RNAi Deal At Alnylam Pharmaceuticals (ALNY) Has Changed Its Investment Story - simplywall.st

simplywall.st - Jun 06, 2026

Alnylam, Inceptive ink AI deal potentially worth $2B - BioPharma Dive

BioPharma Dive - Jun 04, 2026

Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion - Benzinga

Benzinga - Jun 04, 2026

Alnylam Pharmaceuticals (ALNY) Partners with Inceptive Nucleics to Enhance Drug Discovery - GuruFocus

GuruFocus - Jun 05, 2026

Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500 - Barron's

Barron's - Jun 08, 2026

Alnylam Pharmaceuticals (ALNY) director receives 4,393 stock options grant - Stock Titan

Stock Titan - Jun 03, 2026

Alnylam Slides as Investors Refocus on Near-term Amvuttra Growth After Recent AI-deal Headlines - Moomoo

Moomoo - Jun 09, 2026

Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development - Yahoo Finance

Yahoo Finance - Jun 04, 2026

City banks nearly $100M for next-gen RNAi drugs - BioPharma Dive

BioPharma Dive - Jun 08, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment